TY - JOUR
T1 - Outcome of the first Medicines Utilization Research in Africa group meeting to promote sustainable and rational medicine use in Africa
AU - Massele, Amos
AU - Burger, Johanita
AU - Katende-Kyenda, Norah L.
AU - Kalemeera, Francis
AU - Kenaope, Thatoyaone
AU - Kibuule, Dan
AU - Mbachu, Ogochukwu
AU - Mubita, Mwangana
AU - Oluka, Margaret
AU - Olusanya, Adedunni
AU - Paramadhas, Bene D.Anand
AU - Van Zyl, Paulina
AU - Godman, Brian
N1 - Publisher Copyright:
© 2015 Taylor & Francis.
PY - 2015/11/1
Y1 - 2015/11/1
N2 - The first Medicines Utilization Research in Africa group workshop and symposium brought researchers together from across Africa to improve their knowledge on drug utilization methodologies as well as exchange ideas. As a result, progress was made on drug utilization research and formulating future strategies to enhance the rational use of medicines in Africa. Anti-infectives were the principal theme for the 1-day symposium following the workshops. This included presentations on the inappropriate use of antibiotics as well as ways to address this. Concerns with adverse drug reactions and adherence to anti-retroviral medicines were also discussed, with poor adherence remaining a challenge. There were also concerns with the underutilization of generics. These discussions resulted in a number of agreed activities before the next conference in 2016.
AB - The first Medicines Utilization Research in Africa group workshop and symposium brought researchers together from across Africa to improve their knowledge on drug utilization methodologies as well as exchange ideas. As a result, progress was made on drug utilization research and formulating future strategies to enhance the rational use of medicines in Africa. Anti-infectives were the principal theme for the 1-day symposium following the workshops. This included presentations on the inappropriate use of antibiotics as well as ways to address this. Concerns with adverse drug reactions and adherence to anti-retroviral medicines were also discussed, with poor adherence remaining a challenge. There were also concerns with the underutilization of generics. These discussions resulted in a number of agreed activities before the next conference in 2016.
UR - http://www.scopus.com/inward/record.url?scp=84949112646&partnerID=8YFLogxK
U2 - 10.1586/14737167.2015.1088386
DO - 10.1586/14737167.2015.1088386
M3 - Article
C2 - 26367814
AN - SCOPUS:84949112646
SN - 1473-7167
VL - 15
SP - 885
EP - 888
JO - Expert Review of Pharmacoeconomics and Outcomes Research
JF - Expert Review of Pharmacoeconomics and Outcomes Research
IS - 6
ER -